Micronucleated erythrocytes in preterm newborns exposed to phototherapy and/or oxygentherapy

Guillermo M Zúñiga-González1, Belinda C Gómez-Meda, María de Lourdes Lemus-Varela

  • 1Laboratorio de Mutagénesis, Centro de Investigación Biomédica de Occidente, Instituto Mexicano del Seguro Social, Guadalajara, Jalisco, Mexico. mutagenesis95@hotmail.com

Insights

Postnatal treatments like phototherapy can increase DNA damage in preterm newborns (PNBs). This study found a significant rise in micronucleated cells with longer phototherapy exposure in PNBs.

Area of Science:

  • Neonatal Medicine
  • Pediatric Hematology
  • Environmental Health

Background:

  • Preterm newborns (PNBs) possess underdeveloped antioxidant defenses, increasing susceptibility to oxidative stress from medical interventions.
  • Postnatal treatments are essential but may pose risks due to immature physiological systems in PNBs.

Purpose of the Study:

  • To investigate the association between common postnatal treatments and DNA damage in preterm newborns.
  • Specifically, to determine if micronucleated erythrocytes increase following oxygen therapy and/or phototherapy.

Main Methods:

  • Analysis of 72 blood samples from PNBs (26-36 weeks gestation) within 84 hours of birth.
  • Quantification of micronucleated erythrocytes and micronucleated polychromatic erythrocytes as biomarkers of DNA damage.
  • Correlation of DNA damage markers with exposure duration to oxygen therapy and combined phototherapy plus oxygen therapy.

Main Results:

  • No significant increase in DNA damage markers was observed in PNBs receiving only oxygen therapy.
  • A statistically significant increase in micronucleated polychromatic erythrocytes was detected with extended exposure to phototherapy combined with oxygen.
  • These findings suggest phototherapy contributes to observable DNA damage in PNBs' peripheral blood cells.

Conclusions:

  • Phototherapy, particularly when combined with oxygen, appears to induce DNA damage in preterm newborns.
  • Monitoring micronucleated erythrocytes may serve as a sensitive indicator of treatment-related genotoxicity in PNBs.
  • Further research into mitigating oxidative stress from phototherapy in PNBs is warranted.

Related Concept Videos

Erythropoiesis01:14

Erythropoiesis

Red blood cells  (RBCs) transport oxygen to all body tissues. These cells survive only for 120 days and then need to be replenished. Erythropoiesis is the process of RBC production. In healthy individuals, erythropoiesis ensures all tissues are amply supplied with oxygen. In addition, blood loss due to injury leads to a drop in the physiological oxygen level that will cause erythropoiesis. Any defect in erythropoiesis leads to several physiological disorders, including thalassemia, anemia, and...
Factors Affecting Erythropoiesis01:24

Factors Affecting Erythropoiesis

The cardiovascular system regulates the number of erythrocytes in the bloodstream to ensure optimal oxygen transport. It also prevents over-proliferation of these cells, which helps to maintain blood viscosity and flow rate.
Several factors influence the erythrocyte production rate, with tissue oxygen level being among the most critical. Intense exercise or high altitudes can cause tissue hypoxia, which triggers the kidneys to release more erythropoietin (EPO) into the bloodstream.
EPO then...
Disorders of Erythrocytes01:27

Disorders of Erythrocytes

Disorders of erythrocytes, or red blood cells (RBCs), include a range of conditions affecting their number, shape, or function.
Erythrocyte disorders can be broadly categorized into two main types: anemic and polycythemic conditions.
A low oxygen-carrying capacity of the blood due to the loss, lower production, or destruction of erythrocytes is termed anemia. Hemorrhagic anemia, for example, occurs when bleeding from an external wound or internal ulcer reduces erythrocyte counts.
On the other...
Lifecycle of Erythrocytes01:22

Lifecycle of Erythrocytes

Erythrocytes, also known as red blood cells, constantly move through blood capillaries. As a result, they damage their plasma membrane due to the continuous friction. Typically, after 100 to 120 days, erythrocytes become rigid and fragile as they wear out. As they pass through small vessels in the spleen and liver, they can get trapped and break apart into fragments.
The resident phagocytic macrophages deal with these damaged cells by engulfing them and separating their globin and heme groups.